Vol. 2026 · Bill Detail · Special Edition
CivicRadar.Wednesday, September 2, 2026
Free · Stays on your device
An Act to Support Healthy Weight by Providing MaineCare Coverage for Certain Weight Loss Medications
This bill requires the MaineCare program to cover certain weight loss medications called glucagon-like peptide-1 receptor agonists, which are approved by the FDA for treating obesity. Coverage would be limited to prescriptions from a primary care provider or a bariatric specialist and would require prior approval. This change would allow MaineCare recipients to access these specific medications for weight loss if prescribed by an approved provider.
No official summary on file for this bill · generated by Gemini 2.5 Flash from its full text
Want updates?
Get notified when ME LD480 moves stage
Pick a channel below. Every option is opt-in, and we tell you exactly what we store.
We store your email address and the bill ID. We'll send a confirmation link first; alerts only start after you click it. Every email has a one-click unsubscribe.
Coming soon
- RSS feed· Atom 1.0 + JSON Feed per bill
- Bluesky· follow a CivicRadar bot post per status change
- Telegram· channel or DM via bot
- Discord· channel webhook
- WhatsApp· via WhatsApp Business
- SMS· via Twilio